Drug induced obesity
Murakami, T.; Mizushima, Y.
Nihon Rinsho. Japanese Journal of Clinical Medicine 53 Suppl: 425-429
1995
ISSN/ISBN: 0047-1852 PMID: 7563779 Document Number: 440162
Document emailed within 1 workday
Related Documents
Salazar, D.E.; Schentag, J.J.; Corcoran, G.B. 1992: Obesity as a risk factor in drug-induced organ injury. V. Toxicokinetics of gentamicin in the obese overfed rat Drug Metabolism and Disposition: the Biological Fate of Chemicals 20(3): 402-406Corcoran, G.B.; Salazar, D.E. 1989: Obesity as a risk factor in drug-induced organ injury. IV. Increased gentamicin nephrotoxicity in the obese overfed rat Journal of Pharmacology and Experimental Therapeutics 248(1): 17-22
Lumholtz, I.B. 1976: Drug information for nurses. Obesity; therapeutic main group: anorectics, appetite depressants. 3. Complications of obesity Sygeplejersken 76(40): 11
Sankhla, M.; Sharma, T.K.; Mathur, K.; Rathor, J.S.; Butolia, V.; Amita K Gadhok; Vardey, S.K.; Sinha, M.; G.G. Kaushik 2012: Relationship of Oxidative Stress with Obesity and its Role in Obesity Induced Metabolic Syndrome Clinical Laboratory 58(5-6): 385-392
Nishikaze, O. 1975: Drug-drug interaction and drug-induced interference with clinical laboratory test procedures--chairman's introductory remarks Rinsho Byori. Japanese Journal of Clinical Pathology 23(2): 75
Rohner-Jeanrenaud, F.; Seydoux, J.; Chinet, A.; Bas, S.; Giacobino, J.P.; Assimacopoulos-Jeannet, F.; Jeanrenaud, B.; Girardier, L. 1982: Defective diet-induced but normal cold-induced brown adipose tissue adaptation in hypothalamic obesity in rats Journal de Physiologie 78(9): 833-837
Jervell, J. 1973: Drug therapy of obesity Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 93(35): 2590-2591
Dickerson, L.M.; Carek, P.J. 2000: Drug therapy for obesity American Family Physician 61(7): 2131-2138; 2143
Stuart, B. 2007: Believes diet drug use ignores cause of pet obesity Journal of the American Veterinary Medical Association 230(8): 1144
Nigen, S.; Knowles, S.R.; Shear, N.H. 2003: Drug eruptions: approaching the diagnosis of drug-induced skin diseases Journal of Drugs in Dermatology: Jdd 2(3): 278-299
Bach, O.; Kästner, I. 1984: Undesired drug side effects and drug-induced damage. II. Centrally acting drugs Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 39(1): 1-6
Jennum, P.; Kristensen, M.B. 1985: Drug-induced blood dyscrasias. Reports to the Committee on Adverse Drug Reactions 1968-1983 Ugeskrift for Laeger 147(32): 2539-2541
Koriakin, V.A.; Sokolova, G.B.; Ziia, A.V.; Zeliger, L.R.; Ivleva, A.Ia. 1987: Pharmacokinetic bases for the drug-free prevention of drug-induced hepatitis in pulmonary tuberculosis patients Terapevticheskii Arkhiv 59(7): 75-77
Llau, M.E.; Nguyen, L.; Senard, J.M.; Rascol, O.; Montastruc, J.L. 1994: Drug-induced Parkinson syndrome: 10 years of drug vigilance Therapie 49(5): 459-460
Elizarov, A.N.; Razumov, A.N.; Frolkov, V.K. 2007: Non-drug therapy for metabolic disturbances in abdominal obesity Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 1: 21-23
Suter, P.M.; Vetter, W. 2000: Drug therapy of obesity. Strategies for general practice Praxis 89(14): 575-585
Hainer, V. 2010: Drug treatment of obesity--current situation and perspectives Casopis Lekaru Ceskych 149(11): 513-519
Kourounakis, P.N.; Rekka, E.; Hadjipetrou-Kourounakis, L. 1991: Restoration of impaired drug metabolism of rats with adjuvant induced disease by two steroids with different influence on drug biotransformation Die Pharmazie 46(10): 727-729
Streier, K. 1997: Obesity in the service of Justice. new drug-combination leads to protection of the kidney Fortschritte der Medizin 115(32): 54-55
Miyata, Y.; Shimomura, I. 2016: Vitamin D, obesity, and diabetes:new technology toward drug development against metabolic diseases Clinical Calcium 26(3): 385-391